Details checkedStrong evidenceCheckedregulatory

Neuromonics Tinnitus Treatment System

Also known as: Neuromonics Oasis, Neuromonics Sanctuary, Neuromonics app, Neuromonics Tinnitus Treatment

Neuromonics

Primary source

Company

Neuromonics

Program Type

Software/Neurotech

Modality

Neuromodulation

Stage

Marketed

Status

Marketed

Target Gene

—

Route / Mode

Personalized tinnitus sound therapy delivered through app/device workflows and provider-guided assessment

Confidence

88%

Status Confidence

Status confirmed

Evidence Strength

Strong evidence

Last Reviewed

2026-06-10

Geography

United States, Australia, Global

Population

adult, tinnitus, sound-therapy, personalized-audio

Trial IDs

Mechanism

FDA-cleared personalized acoustic therapy using spectrally modified music calibrated to the user’s hearing profile and tinnitus characteristics for neurological retraining.

Indications

Tinnitus

Notes

Adds a major FDA-cleared acoustic tinnitus therapy platform that is currently represented online as app-delivered personalized sound therapy; historically associated with Oasis/Sanctuary device workflows.

Evidence & Sources

3 structured sources

company

Supports: canonicalName, aliases, company, programType, modality, mechanism, status, route

Open

company

Supports: notes, evidenceLevel

Open

regulatory

Supports: allCompanies, stage, notes

Open

Related Programs